Determinants of cisplatin sensitivity in non-malignant non-drug-selected human T cell lines
- 30 June 1992
- journal article
- Published by Elsevier in Mutation Research/DNA Repair
- Vol. 274 (1) , 45-56
- https://doi.org/10.1016/0921-8777(92)90042-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Platinum—DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometryCarcinogenesis: Integrative Cancer Research, 1991
- Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.Journal of Clinical Investigation, 1991
- Host-cell reactivation of cisplatin-damaged pRSVcat in a human lymphoid cell lineCarcinogenesis: Integrative Cancer Research, 1990
- DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host-cell reactivation of damaged plasmid DNABiochemistry, 1989
- The measurement of cisplatin-DNA adduct levels in testicular cancer patientsCarcinogenesis: Integrative Cancer Research, 1988
- Determination of Carcinogen-Induced Macromolecular Adducts in Animals and HumansPublished by S. Karger AG ,1987
- The determination of platinum in biological materials by electrothermal atomic absorption spectroscopySpectrochimica Acta Part B: Atomic Spectroscopy, 1987
- Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.Journal of Clinical Investigation, 1986
- Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II)Biochemistry, 1983